Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,606 public trials 492 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma

NCT07529782

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China

The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

Qilu Hospital of Shandong University Jinan, Shandong, China

Institute of Hematology & Blood Diseases Hospital,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

NCT07523555

Conditions: BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

NCT07032714

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +40 more
Locations: Wake Forest Baptist Health Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

NCT06145581

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

NCT06483100

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

NCT05361694

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: University of Miami Hospitals Miami, Florida, United States

View Trial Details

Recruiting

Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma

NCT04234022

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The Royal Wolverhampton NHS Trust Wolverhampton, United Kingdom

View Trial Details

Recruiting

Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study

NCT07514052

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: ShanxiBethuneH Taiyuan, Shanxi, China

View Trial Details

Recruiting

Study of CAR-T Therapy in Older Patients

NCT04300998

Conditions: Blood Protein Disorders, Cardiovascular Diseases, DLBCL NOS, +19 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions